NCT03166319View on ClinicalTrials.gov

Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) Vasculitis

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

November 24, 2020

Study Completion Date

November 24, 2020

Conditions
Vasculitis, CNSVasculitis, Cerebral
Interventions
DIAGNOSTIC_TEST

MRI, including intracranial vessel wall imaging

MRI/MRA/intracranial high-resolution vessel wall imaging (HR-VWI)

Trial Locations (1)

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03166319 - Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) Vasculitis | Biotech Hunter | Biotech Hunter